10 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
2477546	16	Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.	Centre De Pharmacologie-Endocrinologie (Montpellier, France)
3336026	18	Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.	Merck Sharp & Dohme Research Laboratories
2441054	18	Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.	TBA
3761313	22	Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.	TBA
2848124	401	Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.	Merck Sharp & Dohme Research Laboratories
	16	Conversion of acyclic nonpeptide CCK antagonists into CCK agonists	Glaxo Wellcome Research and Development
16722631	87	An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.	Predix Pharmaceuticals
10377216	4	A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.	Mayo Clinic and Foundation
1501220	52	Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.	Abbott Laboratories
1495013	24	N-methylated analogs of Ac[Nle28,31]CCK(26-33): synthesis, activity, and receptor selectivity.	Hadassah-University Hospital